Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum DRI Healthcare Trust T.DHT.UN

Alternate Symbol(s):  DHTRF

DRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term. Geographically, it has a presence... see more

TSX:DHT.UN - Post Discussion

DRI Healthcare Trust > Another Viewpoint
View:
Post by retiredcf on Jan 16, 2022 8:56am

Another Viewpoint

Lots of companies were declining last week (including almost all of the REITs) as investors are nervous about rising interest rates. GLTA

DHT.UN is a small royalty company, at $267M market cap. It is quite cheap on valuation, but the revenue base is quite low ($26M last quarter). It is in the business of healthcare royalties. It has a decent product portfolio, and we expect it to add more royalties each year. It has only been public a year, but has paid dividends since its listing. The dividend was doubled in November and it declared a 22c special dividend at year end. We find it interesting, but would like to see a bit more public history and performance. But so far so good. 

Provided by 5iResearch. 
Comment by Bamsmba on Jan 16, 2022 9:46am
Interesting and thanks for posting...  5i is correct about the low revenue and the new IPO status, but fail to mention the 90% margin, 10% yield on a 25% cash flow payout and that the management has been doing this work for 15 plus years with great returns. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities